SAKAR HEALTHCARE
Back to Cashflow Statement
|
SAKAR HEALTHCARE Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-31 Cr | ₹-52 Cr | ₹-74 Cr | ₹-90 Cr | ₹-47 Cr |
What is the latest Cash Flow from Investing Activities ratio of SAKAR HEALTHCARE ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-31 Cr |
| Mar2024 | ₹-52 Cr |
| Mar2023 | ₹-74 Cr |
| Mar2022 | ₹-90 Cr |
| Mar2021 | ₹-47 Cr |
How is Cash Flow from Investing Activities of SAKAR HEALTHCARE Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-31 Cr | Negative | |
| Mar2024 | ₹-52 Cr | Negative | |
| Mar2023 | ₹-74 Cr | Negative | |
| Mar2022 | ₹-90 Cr | Negative | |
| Mar2021 | ₹-47 Cr | - | |
Compare Cash Flow from Investing Activities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,008.7 Cr | -11.4% | -23.3% | 155.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,904.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹172,213.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹106,138.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,304.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -11.4% |
-23.3% |
155.1% |
| SENSEX | 0.9% |
-0.8% |
-10.5% |
You may also like the below Video Courses